Boston Scientific's Patent Suit Against J&J Heads To Jury

Law360, New York (July 1, 2005, 12:00 AM EDT) -- In the last of three lawsuits between Boston Scientific Corp. and Johnson & Johnson Inc. over patent rights to cardiovascular stent technology, the jury convened Friday to begin deliberations in Boston Scientific’s patent lawsuit against J&J.

Boston Scientific, which lost two earlier trials to J&J over the lucrative technology, claims J&J's Cypher drug-eluting stent infringes its patents.

In closing arguments on Thursday, Patterson Belknap partner Gregory Diskant told the jury that Johnson & Johnson didn’t infringe Boston Scientific’s patents, which he said were invalid.

“You don't...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.